Reclassifying COVID-19 as seasonal flu, the Japanese government should clarify how it would respond in the event of risk of increased infections and deaths.
The JAPAN Forward team welcomes the New Year with a renewed sense of purpose. Here are some milestones we achieved in 2022 and our vision going...
After a 2-year hiatus due to COVID-19, Emperor Naruhito and the Imperial Family resumed the annual tradition of New Year greetings with the general public.
There is a shocking contrast between the COVID-19 case numbers and deaths announced by Beijing compared to local regions in China.
Asian Americans are concerned about a resurgence of the discrimination suffered by 120,000 Japanese Americans living on the West Coast after December 7, 1942.
Relying on Xocova alone is not enough. It should be used with other available drugs according to their characteristics to suppress a resurgence of COVID-19.
Shionogi's Xocova is Japan's first domestically produced COVID drug to gain approval for practical use as preparation gear up for the "eighth wave."
A former United States Marine looks at 40+ years of US-China dialogue to find how talks have benefitted China but not the peace and stability of...
China takes the spotlight during German Chancellor Olaf Scholz '12 hour trip to China. Meanwhile, favored partner Japan welcomed Germany's Federal President.
Two cities have come up with innovative ways to advertise their Instaworthy townscapes to residents looking for a forever home.
Gathering in person in Tokyo, participants from Japan and around the world debated developing trends in business, travel and leisure sectors.
The same social media accounts spread rumors about the Abe assassination, pro-Russian theories on the Ukraine invasion, and COVID-19 conspiracies.
